Literature DB >> 20953745

AA amyloidosis associated with macroglobulinemia.

Raine Tatara, Tadashi Nagai, Hiroyuki Kobayashi, Kaoru Hatano, Takahiro Suzuki, Kazuo Muroi, Keiya Ozawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953745     DOI: 10.1007/s12185-010-0700-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

1.  Secondary systemic amyloidosis: response and survival in 64 patients.

Authors:  M A Gertz; R A Kyle
Journal:  Medicine (Baltimore)       Date:  1991-07       Impact factor: 1.889

2.  Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

Authors:  J D Gillmore; L B Lovat; M R Persey; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

Review 3.  Waldenström's macroglobulinemia associated with AA amyloidosis.

Authors:  J Gardyn; A Schwartz; R Gal; U Lewinski; D Kristt; A M Cohen
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 4.  Modern treatment of amyloidosis: unresolved questions.

Authors:  Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 5.  Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?

Authors:  Lucio Manenti; Pius Tansinda; Augusto Vaglio
Journal:  Expert Opin Pharmacother       Date:  2008-08       Impact factor: 3.889

Review 6.  Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.

Authors:  Tadashi Nakamura
Journal:  Mod Rheumatol       Date:  2008-03-04       Impact factor: 3.023

7.  Natural history and outcome in systemic AA amyloidosis.

Authors:  Helen J Lachmann; Hugh J B Goodman; Janet A Gilbertson; J Ruth Gallimore; Caroline A Sabin; Julian D Gillmore; Philip N Hawkins
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.